Literature DB >> 8977506

The clinical pharmacology of fexofenadine in children.

F E Simons1, J N Bergman, W T Watson, K J Simons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8977506     DOI： 10.1016/s0091-6749(96)80192-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  12 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Causality assessment of adverse effects: when is re-challenge ethically acceptable?

Authors:  A L Po; M J Kendall
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.

Authors:  K Simpson; B Jarvis
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 5.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 7.  New treatments for allergic rhinitis.

Authors:  S J Tkachyk
Journal:  Can Fam Physician       Date:  1999-05       Impact factor: 3.275

Review 8.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

9.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.

Authors:  Philippe Devillier; Nicolas Roche; Christophe Faisy
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.